An organized reading of the Selank research record

What this site is

Selank Reviews is an independent editorial project that publishes summaries of the peer-reviewed research literature on Selank (TKPRPGP heptapeptide). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The 'reviews' in the domain name reflects our editorial posture: a careful, organized reading of a specific research record — the 25-year body of work on Selank produced primarily at the Institute of Molecular Genetics of the Russian Academy of Sciences and the V.V. Zakusov Research Institute of Pharmacology in Moscow. It does not refer to product reviews, vendor evaluations, or consumer recommendations.

This site has no affiliation with any vendor, retailer, peptide supplier, compounding pharmacy, or telehealth service. We have no financial relationships with any party that manufactures or sells research chemicals, supplements, or pharmaceuticals.

Editorial standards and sourcing methodology

Every factual claim on this site is sourced to a primary publication — a peer-reviewed journal article, conference abstract, or registered scientific review — and carries an inline citation number linking to the full reference entry on the References page.

Our primary source hierarchy:

1. Peer-reviewed journal articles with PubMed indexing (highest weight). All quantitative claims — dose values, HARS scores, IC50 values, sample sizes — are sourced exclusively from this tier.
2. Conference abstracts with a registered DOI (moderate weight). The Syunyakov et al. (2012) rapid/slow responder analysis is a conference abstract (European Psychiatry) with a registered DOI; it is cited specifically for the responder-trajectory finding and labeled as a conference abstract.
3. Narrative evidence reviews (contextual only). The Monis and Maple (2024) review from Medical Anti-Aging is cited for context on the existing literature landscape; its conclusions are not treated as equivalent to primary source data.

We do not cite Wikipedia, social media, Reddit, forum posts, vendor product pages, or any source without a peer-reviewed publication or registered DOI.

Selank is a compound with a predominantly Russian research base — virtually all primary publications originate from two Moscow institutes. We report this as a significant limitation of the existing literature, not as a reason to dismiss the evidence. The research that exists is internally consistent and methodologically specified; the limitation is in the scope and independence of the evidence base, not in its internal validity.

When the research record is uncertain or incomplete, we say so. The dosage page notes explicitly that human pharmacokinetic parameters are absent from the published literature. The research page identifies strain-dependent effects as a genuine complication for human extrapolation. Editorial neutrality means neither overstating what the evidence shows nor dismissing evidence because it originates from a non-Western context.

Regulatory and disclaimer context

Selank is approved in Russia as a prescription nasal spray (trade name Selanc) for generalized anxiety disorder and neurasthenia. It is not approved by the FDA, EMA, or any other Western regulatory authority, and has no active Investigational New Drug (IND) application in the publicly available FDA database.

In the United States and European Union, Selank is classified as a research chemical. It may be acquired for legitimate preclinical research purposes in jurisdictions where this is permitted, but it is not available as a licensed prescription medication.

Athletes subject to drug testing should consult their sporting authority before any research involving Selank. The compound is not specifically named on the current WADA Prohibited List but may fall under the S0 (non-approved substances) category depending on regulatory interpretation.

Nothing on this site constitutes medical advice, a diagnosis, a treatment recommendation, or a prescription. Selank Reviews is an independent editorial digest of publicly available research — not a clinic, not a vendor, and not a source of clinical guidance.